2-(5-Bromo-2-Methylbenzyl)-5-(4-Fluorophenyl)thiophene CAS 1030825-20-7 Purity ≥98.0% (HPLC)

2-(5-Bromo-2-Methylbenzyl)-5-(4-Fluorophenyl)thiophene CAS: 1030825-20-7 Appearance: White or Off-White Powder Purity: ≥98.0% (HPLC)  Intermediate of API (CAS: 842133-18-0) in the treatment of Type 2 Diabetes Mellitus Inquiry: alvin@ruifuchem.com

Products Details

Chemical Properties:

Package: Bottle, Aluminum foil bag, 25kg/Cardboard Drum, or according to customer's requirement Storage Condition: Store in sealed containers at cool and dry place; Protect from light & moistureManufacturer Supply Related Intermediates: 4-Fluorophenylboronic Acid CAS: 1765-93-1 2-(4-Fluorophenyl)thiophene CAS: 58861-48-6 2,3,4,6-Tetrakis-O-Trimethylsilyl-D-Gluconolactone CAS: 32384-65-9 5-Iodo-2-Methylbenzoic Acid CAS 54811-38-0 2-(5-Bromo-2-Methylbenzyl)-5-(4-Fluorophenyl)thiophene CAS: 1030825-20-7 2-(4-Fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]thiophene CAS: 898566-17-1 CAS: 842133-18-0 CAS: 928672-86-0
Item Specifications
Appearance White or Off-White Powder
Purity / Analysis Method  ≥98.0% (HPLC)
Loss on Drying ≤1.00%
Residue on ignition ≤0.50%
Heavy Metals ≤20ppm
Test Standard Enterprise Standard
Usage Intermediate of API (CAS: 842133-18-0)

Description:

Specifications:

Package & Storage:

Chemical Name 2-(5-Bromo-2-Methylbenzyl)-5-(4-Fluorophenyl)thiophene
CAS Number 1030825-20-7
CAT Number RF-PI234
Stock Status In Stock, Production Scale Up to Hundreds of Kilograms
Molecular Formula C18H14BrFS
Molecular Weight 361.27
Melting Point 103℃
Density 1.388
Brand Ruifu Chemical

Advantages:

FAQ:

Application:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of 2-(5-Bromo-2-Methylbenzyl)-5-(4-Fluorophenyl)thiophene (CAS: 1030825-20-7) with high quality. It is an intermediate typically in the synthesis of API (CAS: 461432-26-8). API (CAS: 461432-26-8) is a new antidiabetic drug jointly developed by Bristol-Myers Squibb and AstraZeneca, being approved by the European Medicines Agency (EMA) on November 12, 2012. It is also the first approved SGLT2 inhibitor for the treatment of type II diabetes, being an important option in the treatment of diabetes, and is used to improve glycemic control as an adjunct to dietary and exercise for adults with type II diabetes.

Contact us

Please feel free to give your inquiry in the form below We will reply you in 24 hours